or Try an Advanced Search...

    Disorders Stocks List

    Symbol Grade Name % Change
    ELDN B Eledon Pharmaceuticals, Inc. -7.92
    ELYM B Eliem Therapeutics, Inc 2.68
    LFST B LifeStance Health Group, Inc. -3.58
    NBIX B Neurocrine Biosciences, Inc. -1.10
    IGC B India Globalization Capital Inc. 2.88
    CGTX B Cognition Therapeutics, Inc. 3.14
    IBIO C iBio, Inc. -1.60
    DXR C Daxor Corporation 0.00
    REGN C Regeneron Pharmaceuticals, Inc. 0.59
    PHAT C Phathom Pharmaceuticals, Inc. 2.53
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Biopharmaceutical Medicine Pain Biotechnology Epilepsy Psychiatric Diagnosis Alzheimer's Disease Cardiovascular Disease Clinical Development Geriatrics Medication Parkinson's Disease Vascular Disease Abnormal Psychology Acid Aging Associated Diseases Alcohol Anemia Angioedema Angiogenesis

    Related ETFs - A few ETFs which own one or more of the above listed Disorders stocks.

    Symbol Grade Name Weight
    BBH C Market Vectors Biotech ETF 10.61
    PBE C PowerShares Dynamic Biotech & Genome 10.28
    IBB D iShares Nasdaq Biotechnology Index Fund 9.65
    IBBQ C Invesco Nasdaq Biotechnology ETF 9.51
    MNTL D Tema Neuroscience and Mental Health ETF 8.7
    View all Disorders ETFs...
    Compare ETFs
    Compare BBH to IBB Compare BBH to IBBQ Compare IBB to MNTL

        Disorders Stocks Recent News

        Date Stock Title
        May 10 REGN Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) large institutional owners must be happy as stock continues to impress, up 3.2% over the past week
        May 10 REGN Q1 2024 Intellia Therapeutics Inc Earnings Call
        May 9 NBIX How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
        May 9 NBIX Neurocrine Biosciences Presents CAHtalyst™ Adult Study Baseline Characteristics and Data on Impact of Supraphysiologic Glucocorticoid Therapy at AACE 2024
        May 9 PHAT Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Lags Revenue Estimates
        May 9 NBIX Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1076986 in Healthy Adults
        May 9 PHAT Phathom Pharmaceuticals Non-GAAP EPS of -$1.11 beats by $0.06, revenue of $1.91M misses by $0.23M
        May 9 ELDN Eledon Pharmaceuticals GAAP EPS of -$0.34 beats by $0.04
        May 9 PHAT Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
        May 9 ELDN Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results
        May 9 ELDN Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress
        May 9 REGN Regeneron’s gene therapy triumphs twice, restoring hearing in children
        May 8 NBIX Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1117567 in Healthy Adults
        May 8 REGN Regeneron gene therapy improves hearing in child deafness
        May 8 REGN Regeneron gene therapy improves hearing in two children
        May 8 REGN Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
        May 7 NBIX Neurocrine Biosciences to Present at the BofA Securities 2024 Health Care Conference
        May 7 NBIX Neurocrine Biosciences to Present Phase 3 Baseline Characteristics Data from the CAHtalyst™ Program of Crinecerfont in CAH, and Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH Studies at ECE 2024
        May 7 CGTX Cognition Therapeutics GAAP EPS of -$0.27
        May 7 CGTX Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Medical Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Biopharmaceutical Medicine Pain Biotechnology Epilepsy Psychiatric Diagnosis Alzheimer's Disease Cardiovascular Disease Clinical Development Geriatrics Medication Parkinson's Disease Vascular Disease Abnormal Psychology Acid Aging Associated Diseases Alcohol Anemia Angioedema Angiogenesis
        Disorders

        Disorder may refer to randomness, non-order, or no intelligible pattern. Disorder may also refer to:

        More about Disorders
        Browse All Tags